Related Experiment Video
Updated: Feb 14, 2026

Three-dimensional Alginate-bead Culture of Human Pituitary Adenoma Cells
Published on: February 18, 2016
[The role of miRNAs in the pathogenesis of pituitary adenomas]
Kinga Németh1, Ottó Darvasi2, Nikolette Szücs1
1II. Belgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest.
Abstract:
MicroRNAs (miRNAs) are short, single stranded RNA molecules which play regulatory roles through posttranscriptional regulation of their target genes. Based on our current knowledge, more than 30% of the human protein-coding genes are regulated by miRNAs, hence influencing basic cellular mechanisms including cell proliferation, differentiation and cell death. Differential miRNA expression pattern has been detected in many different types of tumors and, recently, several publications have referred to miRNAs as potential therapeutic targets. Through adjustment of miRNA levels by artificial miRNAs administration or miRNA inhibition, we can influence not only one target gene but also complex biological pathways. Pituitary adenoma is the second most frequent intracranial tumor. In spite of this, the molecular mechanism of the pituitary adenoma formation is not yet entirely revealed. Recently, more and more evidences have been found suggesting that miRNAs have an important role in pituitary adenoma pathogenesis. Here, we summarize the recent results related to this role and highlight the therapeutic potentials in pituitary adenomas. Orv Hetil. 2018; 159(7): 252-259.
Insights
MicroRNAs (miRNAs) regulate gene expression and are implicated in tumor development. This study reviews their role in pituitary adenomas and their therapeutic potential.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression, influencing cellular processes like proliferation and differentiation.
- Dysregulated miRNA expression is observed in various cancers, positioning miRNAs as potential therapeutic targets.
- Pituitary adenoma, a common intracranial tumor, has an incompletely understood molecular pathogenesis.
Purpose of the Study:
- To summarize recent findings on the role of miRNAs in pituitary adenoma development.
- To highlight the therapeutic potential of targeting miRNAs in pituitary adenomas.
Main Methods:
- Review of current scientific literature on miRNAs and pituitary adenomas.
- Analysis of differential miRNA expression patterns in tumor tissues.
- Exploration of miRNA-based therapeutic strategies.
Main Results:
- Emerging evidence indicates a significant role for miRNAs in the pathogenesis of pituitary adenomas.
- miRNAs can influence complex biological pathways by regulating multiple target genes.
- Modulating miRNA levels offers a potential strategy for therapeutic intervention.
Conclusions:
- miRNAs are increasingly recognized as critical players in pituitary adenoma formation.
- Targeting miRNAs presents a promising avenue for novel pituitary adenoma therapies.
More Related Videos
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
12:34Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome
Published on: April 2, 2018
Related Concept Videos
Hypothalamic-Pituitary Axis
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
The Pituitary Gland
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...